In one case report, a patient with a large intra- and extrasellar macroadenoma was found to have a 50 % reduction in tumor size after 5 months of octreotide LAR, despite a failure to normalize IGF-1 and GH levels [65]. This evidence concerns the gene IGF1 and neoplasm.